Latest JMP Stories

SANTA CLARA, Calif., May 11 /PRNewswire-FirstCall/ -- Trident Microsystems, Inc. (Nasdaq: TRID), a leader in high-performance semiconductor system solutions for the multimedia and digital-television markets, today announced that Sylvia Summers Couder, Chief Executive Officer and President, and Pete J. Mangan, Senior Vice President and Chief Financial Officer, will present to investors at the following financial conference: The Eighth Annual JMP Securities Research Conference...

QUEBEC CITY, Oct. 1 /PRNewswire-FirstCall/ -- DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced today that Mr. John Schafer, President and CEO of the Company, will be presenting a company overview at the Third Annual JMP Securities Healthcare Focus Conference on Monday, October 6, 2008, at 1:30 PM (ET). This conference is taking place in New York (New York) on October 6 and 7, 2008. The event...

SOUTH SAN FRANCISCO, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that Alfred G. Merriweather, Senior Vice President and Chief Financial Officer, is scheduled to present a corporate overview at the JMP Securities' Third Annual Healthcare Focus Conference on Tuesday, October 7 at 8:30 a.m. (Eastern Time) at Le Parker Meridien Hotel in New York City. To access the live audio broadcast or the subsequent archived recording, log on to...

Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Third Annual JMP Securities Healthcare Focus Conference, being held at the Le Parker Meridien in New York City. Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present an overview of the Company on Monday, October 6, 2008 at 4:00 p.m. (ET). About Concert Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company dedicated to creating medically and commercially...